REGISTERED NUMBER: 09989614 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30TH APRIL 2026

FOR

OLDFIELD PHARMACIES LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

J M Oldfield

B E Oldfield

REGISTERED OFFICE:

Kano

Wrexham Road

Pentre Bychan

Wrexham

LL14 4DT

REGISTERED NUMBER:

09989614 (England and Wales)

ACCOUNTANTS:

M. D. Coxey and Co. Limited

Chartered Accountants

25 Grosvenor Road

Wrexham

LL11 1BT

BANKERS:

HSBC Bank plc

17-19 Regent Street

Wrexham

LL11 1RN

FIXED ASSETS

Tangible assets

4

1,288

907

CURRENT ASSETS

Debtors

5

42,760

107,362

Cash at bank

37,847

126,873

80,607

234,235

CREDITORS

Amounts falling due within one year

6

511

66,002

NET CURRENT ASSETS

80,096

168,233

TOTAL ASSETS LESS CURRENT LIABILITIES

81,384

169,140

PROVISIONS FOR LIABILITIES

244

172

NET ASSETS

81,140

168,968

CAPITAL AND RESERVES

Called up share capital

7

100

100

Retained earnings

81,040

168,868

SHAREHOLDERS' FUNDS

81,140

168,968

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30th April 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 30th April 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 17th August 2026 and were signed on its behalf by:

J M Oldfield - Director

1.	STATUTORY INFORMATION

Oldfield Pharmacies Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Computer equipment

-

20% on reducing balance

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2025 - 2 ) .

4.	TANGIBLE FIXED ASSETS

Computer

equipment

£

COST

At 1st May 2025

2,619

Additions

999

Disposals

(916

)

At 30th April 2026

2,702

DEPRECIATION

At 1st May 2025

1,712

Charge for year

280

Eliminated on disposal

(578

)

At 30th April 2026

1,414

NET BOOK VALUE

At 30th April 2026

1,288

At 30th April 2025

907

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.4.26

30.4.25

£

£

Trade debtors

-

107,170

Directors' current accounts

42,065

-

Tax

501

-

Prepayments and accrued income

194

192

42,760

107,362

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.4.26

30.4.25

£

£

Tax

-

3,039

Directors' current accounts

-

62,019

Accruals and deferred income

511

944

511

66,002

7.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

30.4.26

30.4.25

value:

£

£

100

Ordinary £1

£1

100

100

8.	CAPITAL COMMITMENTS

30.4.26

30.4.25

£

£

Contracted but not provided for in the

financial statements

-

-

9.	ULTIMATE CONTROLLING PARTY

The controlling party is J M Oldfield.